Skip to content
Search

Latest Stories

GP CPCS delivers ‘unexpected’ insights across Greater Manchester

The GP Community Pharmacist Consultation Service (GP CPCS) is also delivering ‘unexpected’ insights to help transform patient care and facilitate integrated working between pharmacists and GPs across Greater Manchester.

Since April 2021, almost 14,000 appointments have been referred using the GP CPCS across the Greater Manchester Health and Social Care Partnership – a figure that is growing as its success gathers pace and they continue to support practices to increase referral activity.


Joshua Nolan, a pharmacist at Internet Pharmacy in Heywood, one of the first in the area to join the referral service, said: “The number of patients we’re seeing from GP CPCS has been building consistently month-on-month. On average we see around 50 patients, but recently we recorded 53 in just one week.”

The pharmacist, who has been practicing for six years and is also an independent prescriber, believes the GP CPCS has helped bring about more awareness to the clinical services community pharmacy can offer.

He said: “Community pharmacy is perfectly placed to help alleviate some of the pressure on GP practices. There’s more to us than dispensing medication and the support we provided during the pandemic, and through the GP CPCS, is helping raise awareness about the wide range of clinical services people can access through us.”

While the GP CPCS is achieving its objective of relieving the burden on general practice by directing patients with low acuity conditions for care within pharmacy, the Greater Manchester Health and Social Care Partnership has also gained an added benefit of being able to monitor the quality and uptake of the service thanks to the technology managing the referral process.

Alison Scowcroft, a member of the GP CPCS working group, said: “We’ve never had this insight before. The information we can access through EMIS software is helping us to paint a clear picture of where the GP CPCS is working well and where improvements need to be made. It’s helping to strengthen the collaboration between GP practices and community pharmacies.

“By examining the data, we can identify areas where we can improve, such as providing additional training to non-clinical staff to support them in better signposting patients who are suitable for the GP CPCS. The data is so important.”

The introduction of the GP CPCS across Greater Manchester has been well received by GPs. The majority of GP practices are now signed up to the GP CPCS with only 3 per cent still to join.

Luvjit Kandula, a member of the GP CPCS working group, said: “Our original aim was that by March this year, 50 per cent of GP practices would be live with the GP CPCS. But supported by the Winter Access Programme initiatives, we’ve far exceeded that, with 97 per cent of GP practices now signed up. We have seen great collaboration at a local level between general practice and community pharmacy.”

The working group adds that the data generated through EMIS software, during the referral process, is also helping them to better understand patient needs and how community pharmacy can further support the delivery of primary care.  Providing ‘unexpected, but vital’ healthcare insights.

Louise Gatley said: “Over the year we have seen the seasonal health trends you would expect – coughs, colds, and flu like symptoms during the winter months. But we’ve also seen some interesting trends that we can respond to.”

Through the data analytics the working group has been able to track a number of trends, identifying a high level of patients with minor skin conditions and 20 per cent of all referrals to date being for children under the age of 10-years-old.

Pharmacist, Joshua Nolan adds: “The majority of patients we see through the GP CPCS are children, with parents wanting advice and often just reassurance. Most of the referrals are about skin complaints, such as rashes, and more recently there has been an increase in people coming to us for help with Chickenpox and hand, foot and mouth disease.”

Diane Murphy, project officer, Greater Manchester Health and Social Care Partnership, said: “Getting the technology right to support GP CPCS was critical. From a commissioning perspective, the insight, as well as how simply the integration has been for pharmacists and GP practices, is important to ensure we get the full benefits of the service – helping clinicians and achieving better patient outcomes.”

More For You

US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less